Grey-scale ultrasonography for monitoring industrial exposure to hepatotoxic agents.
Industrial exposure to several potentially hepatotoxic agents, such as vinyl-chloride monomer may occur, and there is a need for non-vasive, diagnostic techniques to detect and monitor progressive pathological processes in liver or spleen. Grey-scale ultrasonography permits display of detailed anatomy and pathology in the liver, portal veins, and spleen. The combination of fine resolution, non-invasiveness, absence of ionising radiation hazard, and portable equipment makes the technique ideal for screening populations at risk.
D002617:Chemical Industry; D056486:Chemical and Drug Induced Liver Injury; D004781:Environmental Exposure; D006801:Humans; D006975:Hypertension, Portal / Q000175:diagnosis; D008099:Liver / Q000033:anatomy & histology / Q000098:blood supply; D008107:Liver Diseases / Q000175:diagnosis*; D008991:Monitoring, Physiologic; D009784:Occupational Diseases / Q000139:chemically induced / Q000175:diagnosis*; D011169:Portal Vein; D014159:Transducers; D014465:Ultrasonics / Q000295:instrumentation; D014463:Ultrasonography; D014682:Vena Cava, Inferior; D014752:Vinyl Chloride / Q000009:adverse effects
D014752:Vinyl Chloride